Neuromuscular Complexity During Gait is not Responsive to Medication in Persons with Parkinson’s Disease

The purpose of this study was to investigate the effects of dopaminergic therapy on neuromuscular complexity during gait and on the relationship between neuromuscular complexity and gait speed in persons with Parkinson’s disease (PD). Nine persons with PD walked at self-selected speed for 5 min after having withdrawn from dopaminergic medication for at least 12 h and while optimally-medicated. Electromyographic recordings were taken from eight leg muscles bilaterally. Non-negative matrix factorization was applied to reduce the dimensionality of the electromyographic signals into motor modules. We assessed neuromuscular complexity by investigating the number, structure, and timing of the modules. We also investigated the influence of dopaminergic medication on the relationships between neuromuscular complexity and gait speed. Though gait speed increased significantly after medication intake, medication did not affect neuromuscular complexity. Neuromuscular complexity was significantly associated with gait speed only while the participants were medicated. Thus, the supraspinal structures that govern neuromuscular complexity during gait do not appear to be solely dopaminergically-influenced in PD. The lack of dopaminergic influence on neuromuscular complexity may explain why persons with PD exhibit gait slowness even while medicated, and an intervention that restores neuromuscular complexity may result in gait speed improvement in PD.

[1]  F. Lacquaniti,et al.  Coordination of Locomotion with Voluntary Movements in Humans , 2005, The Journal of Neuroscience.

[2]  J. Pailhous,et al.  Dopa-sensitive and Dopa-resistant gait parameters in Parkinson's disease , 1991, Journal of the Neurological Sciences.

[3]  J. Summers,et al.  The pathogenesis of gait hypokinesia in Parkinson's disease. , 1994, Brain : a journal of neurology.

[4]  S. Lehéricy,et al.  Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. , 2010, The Journal of clinical investigation.

[5]  Stacie A. Chvatal,et al.  Absence of postural muscle synergies for balance after spinal cord transection. , 2013, Journal of neurophysiology.

[6]  Richard R Neptune,et al.  The influence of merged muscle excitation modules on post-stroke hemiparetic walking performance. , 2013, Clinical biomechanics.

[7]  R. Mehanna.  Gait speed in Parkinson disease correlates with cholinergic degeneration , 2014, Neurology.

[8]  B. Galna,et al.  Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease. , 2012, Brain : a journal of neurology.

[9]  W. Weiner,et al.  The clinically important difference on the unified Parkinson's disease rating scale. , 2010, Archives of neurology.

[10]  Dimitri Ryczko,et al.  Forebrain dopamine neurons project down to a brainstem region controlling locomotion , 2013, Proceedings of the National Academy of Sciences.

[11]  Lena H Ting,et al.  A limited set of muscle synergies for force control during a postural task. , 2005, Journal of neurophysiology.

[12]  E Knutsson,et al.  An analysis of Parkinsonian gait. , 1972, Brain : a journal of neurology.

[13]  Richard R Neptune,et al.  Modular control of human walking: a simulation study. , 2009, Journal of biomechanics.

[14]  G M Earhart,et al.  Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? , 2011, Parkinsonism & related disorders.

[15]  S. Grillner,et al.  Neural bases of goal-directed locomotion in vertebrates—An overview , 2008, Brain Research Reviews.

[16]  E. Bizzi,et al.  Central and Sensory Contributions to the Activation and Organization of Muscle Synergies during Natural Motor Behaviors , 2005, The Journal of Neuroscience.

[17]  E. Hirsch,et al.  Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication , 2009, Journal of neurochemistry.

[18]  J. Dingwell,et al.  Kinematic variability and local dynamic stability of upper body motions when walking at different speeds. , 2006, Journal of biomechanics.

[19]  Richard R Neptune,et al.  Three-dimensional modular control of human walking. , 2012, Journal of biomechanics.

[20]  F. Lacquaniti,et al.  Five basic muscle activation patterns account for muscle activity during human locomotion , 2004, The Journal of physiology.

[21]  L. Schiffer,et al.  Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.

[22]  Ryan T. Roemmich,et al.  Ambulation and Parkinson disease. , 2013, Physical medicine and rehabilitation clinics of North America.

[23]  Stacie A. Chvatal,et al.  Decomposing Muscle Activity in Motor TasksMethods and Interpretation , 2010 .

[24]  Richard R Neptune,et al.  The influence of locomotor rehabilitation on module quality and post-stroke hemiparetic walking performance. , 2013, Gait & posture.

[25]  Andrea d'Avella,et al.  Matrix factorization algorithms for the identification of muscle synergies: evaluation on simulated and experimental data sets. , 2006, Journal of neurophysiology.

[26]  L. Defebvre,et al.  Effects of subthalamic nucleus stimulation and levodopa treatment on gait abnormalities in Parkinson disease. , 2003, Archives of neurology.

[27]  Nikolaus R. McFarland,et al.  Defining the Clinically Meaningful Difference in Gait Speed in Persons With Parkinson Disease , 2014, Journal of neurologic physical therapy : JNPT.

[28]  A M Graybiel,et al.  Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Robert A Koeppe,et al.  Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. , 2013, Brain : a journal of neurology.

[30]  Benjamin J. Fregly,et al.  Persons with Parkinson’s disease exhibit decreased neuromuscular complexity during gait , 2013, Clinical Neurophysiology.

[31]  E. Bizzi,et al.  Modules in the brain stem and spinal cord underlying motor behaviors. , 2011, Journal of neurophysiology.

[32]  Maria Grazia Marciani,et al.  Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson’s disease patients , 2008, Journal of Neural Transmission.

[33]  M. Jenkins,et al.  Cueing and gait improvement among people with Parkinson's disease: a meta-analysis. , 2013, Archives of physical medicine and rehabilitation.

[34]  Simon F Giszter,et al.  Motor strategies used by rats spinalized at birth to maintain stance in response to imposed perturbations. , 2007, Journal of neurophysiology.

[35]  Richard R Neptune,et al.  Merging of healthy motor modules predicts reduced locomotor performance and muscle coordination complexity post-stroke. , 2010, Journal of neurophysiology.

[36]  S. Studenski,et al.  History of falls in Parkinson disease is associated with reduced cholinergic activity , 2009, Neurology.

[37]  O. Hornykiewicz,et al.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]. , 1961, Wiener klinische Wochenschrift.

[38]  Mark L. Latash,et al.  Motor Control: Theories, Experiments, and Applications , 2010 .

[39]  Lena H Ting,et al.  Muscle synergy organization is robust across a variety of postural perturbations. , 2006, Journal of neurophysiology.